
Sicagen India Limited
The current stock price of Sicagen India Limited is ₹0.00, with a target price range between ₹0.00 and ₹0.00. The stock has experienced a price change of ₹0.00 (0.00%), reflecting recent market volatility.
Today's opening price was ₹0.00, while the previous close stood at ₹0.00.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Sicagen India Limited Price Chart
Sicagen India Limited Pre Open Market Overview: N/A
Key Metrics:
- IEP (Indicative Equilibrium Price): 0.00
- Previous Close Price: 0.00
- Change: 0.00%
- Total Traded Volume: 0.00
- Total Buy Quantity: 0.00
- Total Sell Quantity: 0.00
Price | Buy Qty | Sell Qty |
---|---|---|
0.00 | 0.00 | 0.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
Bid | Qty | Ask | Qty |
---|---|---|---|
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
0.00 | 0 | 0.00 | 0 |
Shareholding Patterns of Sicagen India Limited
Key Trade Statistics of Sicagen India Limited
Trade Information | Details |
---|---|
Traded Volume (Lakhs) | N/A |
Traded Value (₹ Cr.) | N/A |
Total Market Cap (₹ Cr.) | N/A |
Free Float Market Cap (₹ Cr.) | N/A |
Impact cost | N/A |
Quantity Traded | N/A |
Deliverable Quantity | N/A |
% of Quantity to Traded | N/A |
Security VaR | 24.47 |
Index VaR | N/A |
VaR Margin | 24.47 |
Extreme Loss Rate | 3.5 |
Adhoc Margin | N/A |
Applicable Margin Rate | 27.97 |
Face Value | 10 |
Key Price Statistics of Sicagen India Limited
The 52-week high for Sicagen India Limited was ₹0.00, recorded on N/A. On the other hand, the 52-week low stands at ₹0.00, with the lowest value recorded on N/A.
The upper band for trading is ₹25.90, and the lower band is ₹23.50. The price band is No Band%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.00.
Price Information | Details |
---|---|
52 Week High (-) | 0.00 |
52 Week Low (-) | 0.00 |
Upper Band | 25.90 |
Lower Band | 23.50 |
Price Band (%) | No Band |
Daily Volatility | - |
Annualised Volatility | - |
Tick Size | 0.00 |
Key Securities Statistics of Sicagen India Limited
Securities Information | Details |
---|---|
Status | Permanent Suspended |
Trading Status | Suspended |
Date of Listing | 21-Aug-2008 |
Adjusted P/E | NA |
Symbol P/E | NA |
Index | NA |
Macro-Economic Sector | SERVICES |
Sector | SERVICES |
Industry | TRADING |
Basic Industry | TRADING |
Security Status of Sicagen India Limited
Title | Details |
---|---|
Board Status | Main |
Trading Segment | Normal Market |
Session No. | - |
Class of Shares | Equity |
SDD Compliance | - |
Name of Compliance Officer | - |
Announcements of Sicagen India Limited
Subject | Date |
---|---|
Voluntary Delisting | 08-Jul-2021 |
Voluntary Delisting | 08-Jul-2021 |
Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 06-Jul-2021 |
Resignation | 30-Jun-2021 |
Credit Rating | 29-Jun-2021 |
Trading Window | 29-Jun-2021 |
Related Party Transactions | 01-Jun-2021 |
Financial Result Updates | 26-May-2021 |
Corporate Actions of Sicagen India Limited
Face Value | Purpose | Ex-Date |
---|---|---|
10 | Dividend - Rs 0.50 Per Share | 10-Sep-2020 |
10 | Annual General Meeting/Dividend - Rs 0.4 Per Share | 23-Jul-2019 |
10 | Annual General Meeting / Dividend- Re 0.60 Per Share | 26-Jul-2018 |
10 | Annual General Meeting/Dividend - Re 0.60 Per Share | 19-Jul-2017 |
10 | Dividend - Rs 0.60 Per Share | 08-Sep-2016 |
10 | Dividend - Re 0.60/- Per Share | 10-Sep-2015 |
10 | Annual General Meeting/Dividend Re.0.80/- Per Share | 31-Jul-2014 |
10 | Annual General Meeting / Dividend - Re 1/- Per Share | 19-Jul-2013 |
10 | Annual General Meeting/Dividend Re 1 Per Share | 20-Jul-2012 |
10 | Annual General Meeting And Dividend Re.1/- Per Share | 19-Jul-2011 |
10 | Annual General Meeting | 16-Jul-2010 |
10 | Annual General Meeting | 13-Aug-2009 |
10 | Annual General Meeting | 01-Sep-2008 |
Board Meetings of Sicagen India Limited
Financial Results of Sicagen India Limited
Company Directory of Sicagen India Limited
Web Address | Office | Address | City |
---|---|---|---|
www.sicagen.com | Head Office/ Corporate Office | 4th Floor, SPIC House 88, Mount Road Guindy Chennai | CHENNAI |
www.sicagen.com | Registered Office | 4th Floor, SPIC House No.88, Mount Road, Guindy Chennai | CHENNAI |
www.sicagen.com | Transfer Agent | Cameo Corporate Services Limited Subramanian Building 5th Floor, No 1, Club House Road, | CHENNAI |
Insider Trading of Sicagen India Limited
Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
---|---|---|---|
7(2) | A C MUTHIAH | 2797877 | Sell |
7(2) | ACM EDUCATIONAL FOUNDATION | 8866667 | Sell |
7(2) | SICAL LOGISTICS LTD | 1810000 | Sell |
7(2) | SPIC OFFICERS AND WELFARE FOUNDATION | 411937.5 | Sell |
7(2) | SPIC GROUP COMPANIES EMPLOYEES WELFARE FOUNDATION | 411937.5 | Sell |
Annual Reports of Sicagen India Limited
Investor Complaints of Sicagen India Limited
Event Calendar of Sicagen India Limited
Purpose | Details |
---|---|
Results/Dividend | Inter-alia, to consider and approve the following:- (1) Annual Accounts of the Company for the financial year ended March 31,2011. (2) Audited Financial Results (Standalone & Consolidated Results) for the quarter and financial year ended March 31, 2011.(3) Recommendation of equity dividend, if any for the aforesaid financial year. |
Results/Dividend | Inter alia, to consider and approve the following : (1) Audited Annual Accounts of the Company for the financial year ended March 31, 2012; (2) Audited Financial Results (Standalone & Consolidated Results) for the quarter and financial year ended March 31, 2012; (3) Recommendation of equity dividend, if any for the aforesaid financial year. |
Results/Dividend | Inter alia, to consider and approve the following: (1) Audited Annual Accounts of the Company for the financial year ended March 31, 2013; (2) Audited Financial Results (Standalone & Consolidated Results) for the quarter and financial year ended March 31, 2013; (3) Recommendation of equity dividend, if any for the aforesaid financial year. |
Results | Inter alia, to consider & approve the un-audited financial results of the Company for the quarter ended June 30, 2013. |
Results | To consider & approve inter alia, the un-audited financial results of the Company for the quarter & half year ened September 30, 2013. |
Results | Inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2013. |
Results/Dividend | inter alia, to consider the following: 1. Audited Annual Accounts of the Company for the financial year ended March 31, 2014. 2. Audited Financial Results (Standalone & Consolidated Results) for the quarter and financial year ended March 31, 2014. 3. Recommendation of equity dividend, if any for the financial year ended March 31, 2014. |
Results | To consider & approve inter alia, the un-audited financial results of the Company for the quarter ended June 30, 2014. |
Results | To consider and approve , the un-audited financial results of the Company for the quarter ended September 30, 2014. |
Results | To consider and approve inter-alia the Unaudited Financial Results of the Company for the quarter ended December 31, 2014. |
Results/Dividend | Inter alia, to consider the following: 1)Audited Annual Accounts of the Company for the year ended March 31, 2015. 2) Audited Financial Results (Standalone & Consolidated Results) for quarter and year ended March 31, 2015. 3) Recommendation of equity dividend if any considered, for the year ended March 31, 2015. |
Results | To consider & approve, inter alia, the unaudited financial results of the Company for the quarter ended June 30, 2015. |
Results | To consider & approve, inter alia, the unaudited financial results of the Company for the quarter and half year ended September 30, 2015. |
Results | to consider, inter alia, the unaudited financial results of the Company for the quarter ended December 31, 2015. |
Results/Dividend | To inter alia, consider the (i) audited financial statements for the year ended March 31, 2016 (ii) audited financial results (both standalone & consolidated results) for the quarter and year ended March 31, 2016 (iii) Recommendation of equity dividend, if any considered for the year ended March 31, 2016. |
Results | interalia, to consider & approve the unaudited financial results (both standalone & consolidated results) of the Company for the quarter ended June 30, 2016. |
Results | inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2016. |
Results | to consider, inter alia, the unaudited financial results of the Company for the quarter ended December 31, 2016. |
Results/Dividend | Inter alia, to consider the following :- -Audited Annual Accounts of the Company for the year ended March 31, 2017. -Audited Financial Results (Standalone & Consolidated Results) for the quarter and year ended March 31, 2017. -Recommendation of equity dividend for the year 2016-17. |
Results | interalia, to consider & approve the unaudited financial results of the Company for the quarter ended June 30, 2017. |
Results | interalia, to consider & approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2017 |
Results | Inter alia, to consider and approve the un-audited financial results of the Company for the quarter ended December 31, 2017. |
Financial Results/Dividend | To consider and approve the audited financial results for the quarter and year ended March 31, 2018 and equity dividend if any recommended for the year 2017-18. |
Financial Results | To consider and approve the un-audited financial results of the Company for the period ended Jun 30, 2018. |
Financial Results | To inter alia, consider and approve the un-audited financial results of the Company for the quarter and half year ended September 30, 2018. |
Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
Financial Results | To consider and approve the financial results for the period ended March 31, 2019 |
Financial Results | To consider and approve the unfinancial results for the period ended Jun 30, 2019 |
Financial Results | To consider and approve the unaudited financial results for the period ended September 30, 2019 |
Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
Voluntary Delisting | To consider and approve the proposal for voluntary delisting of equity shares of the Company from National Stock Exchange of India Ltd (NSE) as per Regulation 6(a) & 7 of the SEBI (Delisting of Equity Shares)Regulation, 2009. The equity shares of the Company will remain to be listed on Bombay stock Exchange Ltd (BSE), which has nationwide terminals. |
Voluntary Delisting | SICAGEN : 23-Apr-2020 : The Company has informed the Exchange that a Board meeting scheduled on March 31, 2020 has been now re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 23, 2020 through Video Conference inter alia to consider and approve the proposal for voluntary delisting of shares from National Stock Exchange (NSE). |
Financial Results | The meeting of the Board of Directors of the Company has been scheduled to be held on Wednesday, the 17th June 2020 inter alia, to consider the following:-ᅡᅠAudited annual accounts of the Company for the year ended 31st March 2020.Audited financial results (standalone & consolidated results) for the quarter and year ended 31st March 2020.ᅡᅠRecommendation of equity dividend if any considered for the financial year 2019-20.ᅡᅠThe above intimation may kindly be taken on record. |
Financial Results | The meeting of the Board of Directors of the Company has been scheduled to be held on Friday, 07th August, 2020 inter alia, to consider and approve the unaudited financial results of the Company for the period ended Jun 30, 2020 |
Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters |
Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2021, dividend and other business matters |
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
Share Transfers of Sicagen India Limited
Company | Period | Reg.7 | Reg.40 |
---|---|---|---|
Sicagen India Limited | 31-MAR-2021 | ||
Sicagen India Limited | 30-SEP-2020 | ||
Sicagen India Limited | 31-MAR-2020 | ||
Sicagen India Limited | 30-SEP-2019 | ||
Sicagen India Limited | 31-MAR-2019 |
Voting Results of Sicagen India Limited
Date of Mtg. | Mtg. Type | Resolution |
---|---|---|
17-SEP-2020 | AGM | To receive, consider and adopt the audited Balance Sheet and Profit & Loss Account for the Year Ended March 31, 2020 together with the Reports of Directors and Auditors thereon. |
17-SEP-2020 | AGM | To authorise the Company to advance loans, give guarantee and / or provide security in connection with any loan taken by other entities in which the Directors are interested as per Section 185 of the Companies Act, 2013. |
17-SEP-2020 | AGM | To ratify the appointment of Cost Auditor as per Section 148 and fixing their remuneration as an Ordinary Resolution. |
17-SEP-2020 | AGM | To appoint a Director in the place of Mr.R.Chandrasekar (DIN: 06374821), who retires by rotation and being eligible, offers himself for re-election as an Ordinary Resolution. |
17-SEP-2020 | AGM | To declare equity dividend for the year 2019-20. |
31-JUL-2019 | AGM | To receive, consider and adopt Balance Sheet as at 31st March 2019, statement of profit and loss for the period on that date, reports of directors and auditors thereon. |
31-JUL-2019 | AGM | Ratification of appointment of Mr.J.Karthikeyan as Cost Auditor and fixing of remuneration for financial year 2019-20 |
31-JUL-2019 | AGM | To appoint Mr.R.Chandrasekar (DIN 06374821) as Director as Whole Time Director for a period of 3 years w.e.f 28.11.2018. |
31-JUL-2019 | AGM | To re-appoint Mrs.Sashikala Srikanth (DIN 01678374) as Independent Director for a further period of 5 years w.e.f 11.08.2019. |
31-JUL-2019 | AGM | To re-appoint Mr.B.Narendran (DIN 01159394) as Independent Director for a further period of 5 years w.e.f 11.08.2019. |
31-JUL-2019 | AGM | To appoint Mr.M.Rajamani (DIN 00195006) as Independent Director for a period of 5 years w.e.f 28.11.2018. |
31-JUL-2019 | AGM | To appoint Mr.S.Radhakrishnan (DIN 00061723) as Independent Director for a period of 5 years w.e.f 09.08.2018. |
31-JUL-2019 | AGM | To appoint Mr.S.R.Ramakrishnan (DIN 00120126) as Director of the Company. |
31-JUL-2019 | AGM | To appoint Mr.R.Chandrasekar (DIN 06374821) as Director of the Company. |
31-JUL-2019 | AGM | To appoint a Director in the place of Mr.Ashwin C Muthiah, who retires by rotation, being eligible and offers himself for re-election. |
31-JUL-2019 | AGM | To declare equity dividend for the financial year 2018-19 |
06-AUG-2018 | AGM | Adoption of balance sheet as at 31st March 2018, statement of profit and loss for that period, reports on directors and auditors thereon. |
06-AUG-2018 | AGM | Declaration of equity dividend for the year 2017-18. |
06-AUG-2018 | AGM | Appointment of Director in the place of Mr.Ashwin C Muthiah who retires by rotation and being eligible for re-election. |
06-AUG-2018 | AGM | Ratification of appointment of Mr.J.karthikeyan, Cost Accountant as Cost Auditor of the company and fixing of remuneration for the financial year 2018-19. |
FAQs on Sicagen India Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.